Clinical Trial Update: Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a flexible-dose regimen for Major Depressive Disorder with mixed features has completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Major Depressive Disorder With Mixed Features | Phase 3 | Status: COMPLETED | Results posted: 2015-10-09